Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIBRETTO: Laquinimod vs Avonex in RRMS
NCT01975298Phase 3Withdrawn
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Jan 2014
- Primary completion
- Mar 2014
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of laquinimod in relapsing-remitting multiple sclerosis (RRMS), sponsored by Teva Pharmaceutical Industries Ltd.. Planned start Jan 2014; status: withdrawn.
02
Drugs
laquinimod
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT01975298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01975298.